| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.28 | 3e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-05 |